OPGx-RHO

N/A

Report date: 2024/04/30 17:40:23

Base Information

Drug NameOPGx-RHO
Drug Alias NameIC-100
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionRHO gene transference
TargetsRhodopsin
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Florida Research Foundation IncUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesOpus Genetics Inc
Inactive CompaniesIveric Bio Inc
Active IndicationsRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A